By Ernst & Young The year in review Biotech grows up: key themes for 2016 1. Capital: the view from the top? In 2016, the biopharma world is on somewhat unfamiliar footing. After five years of...
The Role of Technology and Capabilities Similarity and Complementarity By Marcela Miozzo, Lori DiVito, Panos Desyllas Drawing on a multiple case study of acquisitions of UK biopharmaceutical firms,...
By Paul Bjacek – Accenture Contributor: Kurt Eichhorn Mergers and acquisitions in the global chemicals industry have tumbled from their highs of the 2007-2009 period, jolted by the Great Recession...
Firepower Index and Growth Gap Report 2015 By Ernst & Young Biopharma M&A rockets to record heights in 2014 Kaboom! Record biopharma M&A exceeded US$200 billion in 2014, well over twice...
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
Online courses
Onsite programs
Inhouse workshops
